The European Union spent three years debating a ban on inducements, dropped it in the final deal, and replaced it with a value-for-money regime that gives supervisors a quantitative lever over product pricing without ever prohibiting a commission. For cross-border brokers and distributors, the softer-looking outcome is the more demanding one.

The Retail Investment Strategy (RIS) reached political agreement between the Council and the European Parliament on December 18, 2025, amending the Markets in Financial Instruments Directive (MiFID II), the Insurance Distribution Directive (IDD), the Packaged Retail and Insurance-based Investment Products Regulation (PRIIPs), the Undertakings for Collective Investment in Transferable Securities (UCITS) Directive and the Alternative Investment Fund Managers Directive (AIFMD). The headline partial ban on inducements for execution-only and non-advised business was rejected. What replaced it — a mandatory value-for-money assessment benchmarked against product peer groups, plus an explicit right for member states to impose national bans anyway — converts a single EU-wide rule into 27 potentially divergent regimes. This analysis walks through what was actually agreed, how it compares with the jurisdictions that already banned inducements, the enforcement precedent that shows the EU will prohibit a revenue stream when it chooses to, and the 2027–2028 compliance timeline.

Key facts:

• Political agreement: December 18, 2025, Council and European Parliament — Council of the EU press release
• Instruments amended: MiFID II, IDD, PRIIPs, UCITS Directive, AIFMD
• Inducements: blanket and partial bans rejected; replaced by a three-limb inducement test — tangible client benefit, separate cost disclosure, and a strengthened best-interests duty
• Member-state discretion: national inducement bans expressly permitted as gold-plating
• Value for money: manufacturers and distributors must identify and quantify all costs and charges and justify them against peer groupings under MiFID II, UCITS and AIFMD, and against supervisory benchmarks under IDD
• Benchmark design: centralised ESMA and EIOPA benchmarks were dropped in favour of sectoral peer groupings introduced nationally over four years
• Timeline: transposition 24 months after Official Journal publication; application 30 months after; PRIIPs changes 18 months after — placing live application in 2028 on a 2026 publication

Methodology and sources

This analysis rests on the Council of the EU’s December 18, 2025 press release announcing the provisional agreement, the European Parliament’s legislative-train record for the retail investment package, and published client analyses from CMS, Linklaters and Loyens & Loeff, each of which had sight of the agreed text ahead of publication. Industry positions are taken from the European Fund and Asset Management Association’s (EFAMA) published policy papers. Two caveats apply. First, at the time of writing the consolidated legal texts were still being finalised, so article numbering in the final directives may differ from the provisional agreement; nothing here should be treated as a citation to a specific article of the amended MiFID II. Second, application dates are expressed relative to Official Journal publication, which had not occurred, so all calendar dates below are derived rather than official.

What the agreement actually does

The RIS was introduced in May 2023 with a partial inducements ban as its centrepiece: third-party payments would have been prohibited for execution-only and non-advised sales, the segment that covers most retail brokerage flow. That provision did not survive trilogue. In its place sits an inducement test requiring that any third-party payment confer a tangible client benefit, that its cost be disclosed clearly and separately, and that the firm comply with a strengthened obligation to act honestly, fairly and professionally in the client’s best interests.

The value-for-money regime is where the substance moved. Under the agreement, product manufacturers and distributors must identify and quantify all costs and charges attaching to a packaged retail investment product, insurance-based investment product, UCITS or retail-facing AIF, then assess whether those costs are justified and proportionate by reference to comparable products. A product that fails the assessment cannot be approved for sale. This is not a disclosure obligation. It is a product-approval gate with a pricing test inside it.

The value-for-money test is best understood as a supervisory pricing benchmark embedded in product governance rather than a cost cap. Under the December 2025 agreement, manufacturers must quantify every cost and charge in a retail product and justify the total against a peer grouping of comparable products; distributors must run an equivalent assessment on the distribution layer. Where costs cannot be justified as proportionate to the value delivered, the product fails its approval process and cannot be marketed to retail clients. Critically, the agreement moved away from the Commission’s original design of centralised benchmarks published by ESMA and EIOPA, and toward sectoral peer groupings introduced by national authorities over a four-year phase-in. The practical effect is that the same fund may clear the test in one member state and fail it in another, depending on how the local peer group is drawn.

Marketing rules tightened in parallel. The agreement strengthens the requirement that marketing communications be fair, clear and not misleading, with explicit attention to risks arising from social-media promotion — a direction that mirrors the convergence between the SEC’s marketing rule and the FCA’s promotions gateway on endorsements.

Jurisdiction / Regulator	Effective date	Scope	Key requirement	Enforcement position
EU (national CAs under RIS)	Application ~30 months after OJ publication (2028 on a 2026 publication)	MiFID II firms, IDD distributors, UCITS and retail AIF manufacturers	Inducement test plus mandatory value-for-money assessment against peer groupings	No enforcement record; product-approval gate is the primary sanction
EU (MiFIR, order flow)	June 30, 2026	Investment firms executing retail order flow	Article 39a MiFIR prohibits payment for order flow; national carve-outs sunset	Outright prohibition — the EU’s demonstrated willingness to ban a revenue line
Netherlands (AFM)	January 1, 2014	Investment firms distributing to retail clients	National ban on commission for investment services	12 years of supervisory practice; the RIS gold-plating clause preserves it
United Kingdom (FCA)	December 31, 2012 (RDR)	Retail investment advisers	Adviser charging replaces commission; separate FCA promotions gateway	Outside the RIS entirely; UK divergence widens
United States (SEC)	June 30, 2020	Broker-dealers making recommendations to retail customers	Regulation Best Interest — conflict mitigation and disclosure, no commission ban	Disclosure-and-mitigation model; payment for order flow remains lawful

Sources: Council of the EU; CMS legal update on the political agreement; European Parliament legislative train. Last updated: August 7, 2026.

How the jurisdictions diverge — and where the arbitrage sits

The table exposes a structural point the “EU rejects inducements ban” headline obscures. Europe now runs three models simultaneously. The Netherlands and the United Kingdom operate hard prohibitions dating from 2014 and 2012 respectively. The rest of the EU will operate a justification test. And under MiFIR, all EU firms face an outright ban on one specific inducement — payment for order flow — from June 30, 2026.

That last point matters more than it first appears, because it demonstrates capability. The EU has shown it will prohibit a revenue stream outright when it concludes the conflict is unmanageable, as our coverage of the June 30 PFOF cliff and the transatlantic split it created set out. The RIS decision not to ban inducements is therefore a policy choice, not a limitation — and the medium-term review clause written into the agreement keeps the option open.

For firms operating cross-border, the fragmentation risk is concrete. A distributor passporting into eight member states may face a national inducement ban in one, a permissive test in six, and a peer grouping in the eighth that classifies its flagship product against a cheaper comparator set. The RIS was presented as harmonisation; on inducements and on benchmark construction it delivers optionality to member states, and optionality is what produces divergence. The EU’s recent record on uniform implementation is not encouraging — only 20% of EU crypto firms converted to full MiCA authorisation before the transition deadline, and national supervisory capacity varied widely.

“It is positive that we now strengthen the framework for retail investments, making it easier for citizens and businesses to access diverse, efficient investment opportunities. At the same time, it will provide a welcome boost in terms of the EU financial market’s contribution to our overall competitiveness.”

— Stephanie Lose, Danish Minister for Economic Affairs
(Council of the European Union)

Enforcement context: what the regime will actually bite on

The RIS has no enforcement record, because it is not in force — a material caveat, and firms should treat confident predictions of supervisory intensity with scepticism. What can be assessed is the direction of existing enforcement under the instruments the RIS amends, plus the one hard prohibition already scheduled.

Article 39a of MiFIR, introduced by the MiFIR review, prohibits investment firms from receiving payment for order flow when executing retail client orders, with national carve-outs in member states where the practice was previously permitted expiring on June 30, 2026. Germany’s carve-out was the most commercially significant, and its expiry removed a material revenue line from neobrokers serving German retail clients. That is the clearest evidence of how the EU treats an inducement it deems unmanageable: not a justification test, but a prohibition with a dated sunset.

Under MiFID II as it stands, supervisory attention on inducements has concentrated on documentation rather than the existence of the payment. National competent authorities including BaFin, the AMF and the CNMV have consistently identified weak suitability files and opaque cost-and-charges reporting as the recurring failures in their enforcement reporting. BaFin’s published position is that a firm may neither accept nor grant inducements in respect of persons who are no longer its clients, on the basis that no continuing quality enhancement can be demonstrated. The AMF requires that where inducements relate to non-independent advice, retail clients receive the costs-and-charges document — including third-party payments — at the same time as the suitability report.

Read forward, that pattern suggests where RIS enforcement lands. The value-for-money regime creates a documentary artefact — the cost quantification and peer-group justification — that a supervisor can request, test and find inadequate without ever litigating whether a particular commission was excessive. It converts a subjective conflicts judgement into a file review. Firms that have watched ESMA’s common supervisory action on CFD conflicts will recognise the mechanism.

What this means for brokers, distributors and compliance teams

For retail brokers and contract-for-difference providers, the immediate question is whether third-party payments in the business model survive the tangible-benefit limb. Rebates, platform fees paid by product manufacturers and revenue-sharing arrangements will each need a documented benefit rationale that is specific rather than generic. “Access to a wider product range” was sufficient under the MiFID II quality-enhancement test in many jurisdictions; the strengthened best-interests formulation makes that a weaker position.

For product manufacturers, including UCITS management companies and retail AIF managers, the work is quantitative and it starts before the rules apply. Building a defensible peer grouping requires cost data on comparable products, a documented methodology for selecting comparators, and a governance record showing the assessment fed into product approval. Firms that wait for national benchmarks to be published will be constructing this evidence retrospectively, against a benchmark they did not anticipate.

For distributors, the obligation is separate and additive. The distribution layer carries its own value-for-money assessment, meaning a firm can be obliged to decline a product that its manufacturer has already approved. That is a commercial conversation, not just a compliance one, and it will need contractual support in distribution agreements.

For non-EU firms, including UK manufacturers with EU distribution networks, the reach is indirect but real. EU distributors will require cost data and justification support from manufacturers regardless of where those manufacturers are established. UK firms operating post-RDR are in a stronger position on adviser charging but have no equivalent peer-group benchmarking apparatus, and the UK’s separate trajectory — visible in the FCA’s October 2027 gateway timetable — means convergence should not be assumed.

“If we want to increase retail participation in capital markets, the debate around the retail investment strategy should focus on more than just commissions and costs. We need to talk about creating value for investors, assessing their different needs and goals, and looking across the entire investment”

— Tanguy van de Werve, Director General, European Fund and Asset Management Association (EFAMA)
(EFAMA)

EFAMA’s substantive objection is worth stating precisely, because it is the strongest argument against the regime: the association has proposed removing quantitative value-for-money benchmarks on the grounds that they move supervisors toward market price setting, favouring instead qualitative and quantitative value assessments across the whole value chain, overseen by national supervisors and built on existing MiFID II requirements. That critique is not self-serving cost-avoidance dressed up as principle; a peer-group test applied mechanically does push a regulator into judging price, which is not a role most EU supervisors have historically claimed.

The forward view

Three things determine how demanding this regime becomes. The first is Official Journal publication, which starts every clock in the package. Technical work to finalise the legal texts was scheduled for early 2026; on a 2026 publication, transposition falls in 2028 and application in mid-2028, with the PRIIPs changes arriving roughly a year earlier. Firms budgeting for this should assume 2028, not 2027.

The second is national benchmark construction. Because the agreement replaced centralised ESMA and EIOPA benchmarks with sectoral peer groupings introduced nationally over four years, the substance of the test will be written by national competent authorities rather than at EU level. The methodology each authority adopts — how narrowly a peer group is drawn, whether distribution costs sit inside or outside the comparison — will matter more to any given product than the directive text does. Firms with meaningful EU distribution should be engaging with national consultations as they open, not reading the final rules.

The third is the review clause. The agreement preserves a medium-term review of the inducement regime, which means the ban that was rejected in December 2025 is deferred rather than dead. If national bans spread under the gold-plating clause — and the Dutch precedent gives cover to any government minded to follow — the review will face a fragmented market and a ready-made argument for harmonising upward. The realistic base case is that the EU revisits the ban within a decade, having first built the cost data infrastructure that would make it enforceable.

FAQ

Did the EU ban inducements under the Retail Investment Strategy?

No. The partial ban proposed for execution-only and non-advised sales was rejected in the December 18, 2025 political agreement. It was replaced by an inducement test requiring a tangible client benefit, clear and separate cost disclosure, and compliance with a strengthened duty to act in the client’s best interests. Individual member states may still impose national bans as gold-plating, and a review of the inducement regime is preserved for the medium term.

What is the value-for-money test?

It is a product-approval requirement. Manufacturers and distributors must identify and quantify all costs and charges on a retail investment product and assess whether they are justified and proportionate against comparable products. Products that fail cannot be approved for sale to retail clients. It applies across PRIIPs, insurance-based investment products, UCITS and retail-facing AIFs, and it operates through product governance rather than through disclosure.

Who sets the benchmarks?

Not ESMA and EIOPA centrally, as originally proposed. The final agreement uses sectoral peer groupings under MiFID II, UCITS and AIFMD, alongside supervisory benchmarks under the IDD, introduced by national authorities over a four-year period. This is the single most consequential design change: the substance of the test will be determined nationally, so the same product may pass in one member state and fail in another.

When do the rules apply?

Timelines run from Official Journal publication, which had not occurred at the time of writing. Member states must transpose within 24 months of publication, and the rules apply 30 months after publication, with PRIIPs changes applying at 18 months. On a 2026 publication that places general application in 2028. Firms should plan on 2028 rather than 2027 while treating all derived dates as provisional.

Does this affect UK or other non-EU firms?

Indirectly but materially. UK and other non-EU manufacturers with EU distribution networks will be asked by their EU distributors for the cost data and justification needed to complete value-for-money assessments. The UK itself remains outside the regime, having banned commission for retail investment advice under the Retail Distribution Review from the end of 2012, and it has no equivalent peer-group benchmarking apparatus.

How does this relate to the EU’s payment-for-order-flow ban?

They are separate instruments with opposite designs. Article 39a of MiFIR prohibits payment for order flow outright for retail order execution, with national carve-outs expiring on June 30, 2026. The RIS, by contrast, declined to prohibit inducements and imposed a justification test instead. Together they show the EU distinguishing between conflicts it considers unmanageable and those it believes disclosure and testing can contain.

What should compliance teams do first?

Build the cost data before the benchmarks exist. The binding constraint will be evidential: a documented methodology for selecting comparators, quantified costs at both manufacturing and distribution layers, and a governance record showing the assessment fed product approval. Firms should also review third-party payment arrangements against the tangible-benefit limb, since generic justifications that satisfied the MiFID II quality-enhancement test are a weaker position under the strengthened wording.

This article is informational analysis only and does not constitute legal, regulatory, tax, or investment advice. Regulatory frameworks change frequently and interpretation depends on facts and circumstances; primary documents and official regulator guidance always supersede summaries. Firms should consult qualified legal counsel and their relevant supervisory authority before taking any action based on the analysis above.